FundedIQ
Biotechnology

Epic-Bio: Funding, Investors & Team (Sep 2026)

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

www.epic-bio.com LinkedIn South San Francisco, United States 11-50 employees Founded 2018
Total raised
$145M
Rounds
2
Latest
Series C
Aug 2026

Epic-Bio has raised $145M across 2 funding rounds on record, the most recent a Series C of $90.0M announced in Aug 2026.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Epic-Bio Company Profile and Key Stats

Total funding raised
$145M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series C
$90.0M in Aug 2026
Employees
11-50
reported band
Founded
2018
Headquarters
South San Francisco, United States
Investors on record
11
5 named below

Latest funding round on record: Aug 2026.

Epic-Bio Funding Rounds

Date
Round
Amount
Series C
$90.0M
Series A
$55.0M

Epic-Bio raised $55.0M in a Series A announced in Jul 2022.

4.1 years later, a Series C of $90.0M was announced in Aug 2026.

Epic-Bio Investors

Cormorant Asset Management Janus Henderson Investors Sanofi Ventures Fidelity Octagon Capital Advisors

11 investors are recorded in total; the 5 named above are those the record identifies.

Epic-Bio Founders and Leadership Team

Name
Role
Contact
Amber Salzman
CEO
Locked

Contact details for the Epic-Bio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Epic-Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
29,795
$7.5M
1,822
$58M

Epic-Bio's latest round of $90.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Epic-Bio in Biotechnology and South San Francisco

Companies Similar to Epic-Bio

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Epic-Bio Funding FAQs

What does Epic-Bio do?

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

How much funding has Epic-Bio raised?

Epic-Bio has raised $145M across 2 rounds on record. The most recent is a Series C of $90.0M announced in Aug 2026.

When did Epic-Bio last raise funding?

Epic-Bio's most recent funding round on record is a Series C of $90.0M, announced in Aug 2026.

Who has invested in Epic-Bio?

Investors on record for Epic-Bio include Cormorant Asset Management, Janus Henderson Investors, Sanofi Ventures, Fidelity, Octagon Capital Advisors. FundedIQ records 11 investors in total.

Who is the CEO of Epic-Bio?

Amber Salzman is listed as CEO at Epic-Bio.

Where is Epic-Bio headquartered?

Epic-Bio is based in South San Francisco, California, United States.

How many employees does Epic-Bio have?

Epic-Bio is in the 11-50 employee band.

When was Epic-Bio founded?

Epic-Bio was founded in 2018.

How does Epic-Bio's funding compare to other Biotechnology startups?

Epic-Bio's latest round of $90.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Epic-Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Epic-Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.